Results 1 to 10 of about 296,168 (209)

HUS and atypical HUS [PDF]

open access: yesBlood, 2017
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy characterized by intravascular hemolysis, thrombocytopenia, and acute kidney failure. HUS is usually categorized as typical, caused by Shiga toxin-producing Escherichia coli (STEC) infection,
Al-Nouri   +135 more
core   +6 more sources

Personnel well-being and potentially traumatic COVID-19 pandemic related events (PTES) in the hus helsinki university hospital – baseline results

open access: yesEuropean Psychiatry, 2021
Introduction A majority of the Finnish COVID-19 pandemic patients have been cared for in the HUS Helsinki University Hospital since March 2020. Objectives June 2020 baseline results of an ongoing prospective cohort study are reported.
T. Laukkala   +9 more
doaj   +1 more source

Efficacy and confounding factors of CT attenuation value differences in distinguishing acute and old vertebral compression fractures: a retrospective study

open access: yesBMC Musculoskeletal Disorders, 2023
Purpose To evaluate the influence of various factors on CT attenuation values (HUs) of acute and old fracture vertebra, and to determine the efficacy of HU differences (△HUs) in the differentiation of the two type of fractures.
Limin Liang   +10 more
doaj   +1 more source

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome [PDF]

open access: yes, 2016
Background: The role of complement in the atypical form of hemolytic uremic syndrome (aHUS) has been investigated extensively in recent years. As the HUS-associated bacteria Shiga-toxin-producing Escherichia coli (STEC) can evade the complement system ...
Bakker, J.A. (Jaap)   +14 more
core   +9 more sources

Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study.

open access: yesPLoS ONE, 2022
BackgroundThe role of antibiotics in the treatment of Shiga toxin-producing Escherichia coli (STEC) infection is controversial.ObjectivesTo evaluate the association between treatment (antibiotics, antidiarrheal agents, and probiotics) for STEC infection ...
Shota Myojin   +12 more
doaj   +1 more source

Isolation and characterization Shiga toxin-producing Escherichia coli from sheep and goats inJordanwith evidence of multiresistant serotype O157:H7

open access: yesVeterinární Medicína, 2005
Ninety-three rectal swabs of lambs and young goats from two extensively and two intensively managed herds in Jordanwere taken and examined for Shiga toxin-producing Escherichia coli (STEC).
R. Novotna   +5 more
doaj   +1 more source

The hemolytic uremic syndrome: a possible etiological role of Campylobacter infection

open access: yesAlʹmanah Kliničeskoj Mediciny, 2020
Hemolytic uremic syndrome (HUS), one of the forms of thrombotic microangiopathy, is a severe emergency with non-immune (Coombs negative) anemia, thrombocytopenia and acute renal injury.
G. S. Karpovich   +5 more
doaj   +1 more source

Epidemiology of Shiga toxin-producing Escherichia coli O157:H7 in Africa in review

open access: yesSouthern African Journal of Infectious Diseases, 2018
Shiga toxin-producing Escherichia coli (STEC) O157:H7 is responsible for intestinal and extra-intestinal disease syndromes in human. Isolation of the pathogen from animals, food, clinical samples and environment has been reported from all continents.
Athumani M. Lupindu
doaj   +1 more source

Ockham’s razor defeated: about two atypical cases of hemolytic uremic syndrome

open access: yesBMC Nephrology, 2020
Background Medical investigation is a favorite application of Ockham’s razor, in virtue of which when presented with competing hypotheses, the solution with the fewest assumptions should be privileged. Hemolytic uremic syndrome (HUS) encompasses diseases
Chloe Schwarz   +11 more
doaj   +1 more source

Effect of ultrasound pretreatment on structural, physicochemical, rheological and gelation properties of transglutaminase cross-linked whey protein soluble aggregates

open access: yesUltrasonics Sonochemistry, 2021
A solution (10%, w/v) of whey protein soluble aggregates (WPISA) was pretreated with high-intensity ultrasound (HUS, 20 kHz) for different durations (10–40 min) before incubation with transglutaminase (TGase) to investigate the effect of HUS on the ...
Tiehua Zhang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy